Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MERIT MEDICAL SYSTEMS INC Director's Dealing 2021

Mar 17, 2021

31049_dirs_2021-03-17_3da278a6-3eb6-4997-914f-ff55399a00ef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-03-15

Reporting Person: Millner F. Ann (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-15 Common Stock, No Par Value M 4246 $21.98 Acquired 15476 Direct
2021-03-15 Common Stock, No Par Value F 1552 $60.15 Disposed 13924 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-15 Non-qualified stock options (right to buy) $21.98 M 4246 Disposed 2022-07-16 Common Stock (4246) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Unit $ 2021-06-22 Common Stock (4188) 4188 Direct
Non-qualified stock options (right to buy) $18.8 2023-05-26 Common Stock (10000) 10000 Direct
Non-qualified stock options (right to buy) $34.4 2024-05-24 Common Stock (20000) 20000 Direct
Non-qualified stock options (right to buy) $50.5 2025-06-07 Common Stock (25000) 25000 Direct
Non-qualified stock options (right to buy) $52.17 2026-05-24 Common Stock (13750) 13750 Direct
Non-qualified stock options (right to buy) $52.17 2026-05-31 Common Stock (7500) 7500 Direct

Footnotes

F1: In the Reporting Person's Form 4 filed on June 24, 2020, the number of these options was incorrectly listed at 4,264 when the correct number of options was 4,246.

F2: Becomes exercisable in equal annual installments of 20% commencing 07/16/2016.

F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting.

F4: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.

F5: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.

F6: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.

F7: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.

F8: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.